Last deal

Amount

Non-equity Assistance

Stage

31.03.2022

Date

6

all rounds

$3.8M

Total amount

General

About Company
Maxwell Plus is an AI platform that provides data-driven clinical diagnostics for prostate cancer at an early stage.

Industry

Sector :

Subsector :

Also Known As

Maxwell MR, Maxwell Plus

founded date

01.09.2016

Number of employees

Company Type

For Profit

Last funding type

Non-equity Assistance

IPO status

Private

Description

The company's platform combines machine learning with medical imaging to improve diagnostic accuracy and patient outcomes. It seamlessly integrates with existing systems and connects businesses with clinics offering prostate cancer testing. Founded in 2016 and based in Brisbane, Queensland, Maxwell Plus aims to accelerate the design, development, and delivery of clinical diagnostics built upon medical imaging and pathology data.
Contacts